Fusion event
HBV-CEP290 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
GAGGCATACTTCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGAGGCTGTAGGCATAAATTGG| |TCTGCGCACCAGCACCATGCAACTTTTTCACCTCTGCCTAATCATCTCTTGTTCATGTCCTACTGTTCAAGCCTCCAAGCTGTGCCTTGGGTGGCTTTGG
End
88479719/88085942 (Hg38)
Nearest miRNA
hsa-let-7i/Upstream/1340793; hsa-mir-1178/Downstream/6475847;
Upstream sequence
TTAAATAGTGAATTCAAATTAACTATATCTGCTGTTCATTATTGGCTATTAGAAACATTATAGGAGAATAGAAAAATAGTGAAATTAGCAATAGATTCAT
Downstream sequence
CATTCTATGCATTGCCCTCATAAAGAAATATTATTTAGAAAGCCCCCCAAACATACCAAATAATACACTAATCAAAATGCAAATTCTTCTAATTACCTCT
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.